BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 6:27:00 PM | Browse: 1227 | Download: 1340
 |
Received |
|
2013-11-12 15:27 |
|
Peer-Review Started |
|
2013-11-13 14:17 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-12-31 14:35 |
|
Revised |
|
2014-01-03 04:58 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-03-17 14:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-03-17 14:51 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-04-18 20:18 |
|
Publish the Manuscript Online |
|
2014-04-28 14:14 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abraham S Kanate, Marcelo C Pasquini, Parameswaran N Hari and Mehdi Hamadani |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mehdi Hamadani, MD, Associate Professor of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, United States. mhamadani@mcw.edu |
| Key Words |
Acute myeloid leukemia; Allogeneic hematopoietic cell transplantation; Reduced intensity conditioning; Myeloablative conditioning; Haploidentical; Umbilical cord blood |
| Core Tip |
Acute myeloid leukemia (AML) represents a heterogeneous group of high-grade myeloid neoplasms of the elderly with variable outcomes. We discuss the role of allo-hematopoietic cell transplantation (HCT) in AML patients stratified by cytogenetic- and molecular-risk in first complete remission, as well as allo-HCT as an option in relapsed/refractory AML. |
| Publish Date |
2014-04-28 14:14 |
| Citation |
Kanate AS, Pasquini MC, Hari PN, Hamadani M. Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions. World J Stem Cells 2014; 6(2): 69-81 |
| URL |
http://www.wjgnet.com/1948-0210/full/v6/i2/69.htm |
| DOI |
http://dx.doi.org/10.4252/wjsc.v6.i2.69 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
